920
Participants
Start Date
July 31, 2004
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2013
Cytarabine
100mg/m² kont. i.v. day 1-7 (induction therapy) 3g/m² 2x/die i.v. day 1,3,5 or day 1,2,3
Idarubicin
12mg/m² i.v. day 1,3,5 (first induction cycle) 12mg/m² i.v. Tag 1,3 (second induction cycle)
Etoposide
100mg/m² i.v. day 1-3 (induction therapy)
All-trans retinoic acid
45mg/m² p.o. day 6-8 (induction therapy) 15mg/m² p.o. day 9-21 (induction therapy) 15mg/m² p.o. day 6-21 (consolidation therapy)
Pegfilgrastim
6mg s.c day 10 (cohort 1), 6mg s.c. day 8 (cohort 2)
Center of Hematology and Oncology, Hanusch-Hospital, Vienna
Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern, Linz
Medical Department III, St. Johann-Hospital, Salzburg
Department of Hematology/Oncology, University Hospital Innsbruck, Innsbruck
Department of Oncology and Hematology, University Hospital Eppendorf, Hamburg
Medical Department II, Hematology and Oncology, General Hospital Altona, Hamburg
Medical Department II, University Hospital of Kiel, Kiel
Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH, Oldenburg
Medical Department I, Hospital Bremen-Mitte, Bremen
Medical Department III, Hospital Hannover-Siloah, Hanover
Department of Hematology, Hematology and Oncology, Medizinische Hochschule Hannover, Hanover
Medical Department IV, University Hospital of Giessen, Giessen
Centre of Internal Medicine, University Hospital Göttingen, Göttingen
Clinical Center of Hematology and Oncology, University Hospital of Düsseldorf, Düsseldorf
Medical Department I, Helios Hospital Wuppertal, Wuppertal
Department of Hematology and Oncology, Hospital Essen Süd, Ev. Hospital of Essen-Werden, Essen
Department of Internal Medicine, Wilhelm-Anton-Hospital gGmbH, Goch
Department of General Internal Medicine, University Hospital of Bonn, Bonn
Medical Department I, Hospital of Barmherzige Brüder, Trier
Department of Hematology and Internal Oncology, University Hospital of Mainz, Mainz
Department of Hematology and Oncology, Hospital of Lüdenscheid, Lüdenscheid
Medical Department III, Hematology/Oncology, University of Frankfurt, Frankfurt
Medical Department III, Clinical Center Hanau, Hanau
Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst, Frankfurt
Department of Hematology and Oncology, Caritas Hospital St. Theresia, Saarbrücken
Department of Internal Medicine I, University Hospital of Saarland, Homburg
Department of Internal Medicine/Hematology and Oncology, Cartias Hospital Lebach, Lebach
Department of Oncology, Clinical Center of Stuttgart, Stuttgart
Medical Department II, Diakonie Hospital, Stuttgart
Department of Internal Medicine II, University Hospital of Tübingen, Tübingen
Medical Department II, City Hospital Karlsruhe gGmbH, Karlsruhe
Medical Clinic II-Hematology/Oncology, Hospital Villingen-Schwenningen, Villingen-Schwenningen
Internal Medicine I, University of Freiburg, Freiburg im Breisgau
Medical Department III, Clinical Center Rechts der Isar, München
University of Ulm
OTHER